SC 13G
BIOLINERX LTD.
- Company
- BioLineRx Ltd.
- Filed
- February 8, 2019
- Accession Number
- 0000902664-19-000752
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →